Bio-Techne Corporation (TECH)
NASDAQ: TECH · IEX Real-Time Price · USD
77.29
+1.69 (2.24%)
At close: May 3, 2024, 4:00 PM
76.80
-0.49 (-0.63%)
After-hours: May 3, 2024, 5:30 PM EDT
Bio-Techne Revenue
Bio-Techne had revenue of $1.14B in the twelve months ending December 31, 2023, with 2.25% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $272.60M with 0.37% year-over-year growth. In the fiscal year ending June 30, 2023, Bio-Techne had annual revenue of $1.14B with 2.81% growth.
Revenue (ttm)
$1.14B
Revenue Growth
+2.25%
P/S Ratio
10.61
Revenue / Employee
$375,410
Employees
3,050
Market Cap
12.15B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
Jun 30, 2020 | 738.69M | 24.69M | 3.46% |
Jun 30, 2019 | 714.01M | 71.01M | 11.04% |
Jun 30, 2018 | 642.99M | 79.99M | 14.21% |
Jun 30, 2017 | 563.00M | 63.98M | 12.82% |
Jun 30, 2016 | 499.02M | 46.78M | 10.34% |
Jun 30, 2015 | 452.25M | 94.48M | 26.41% |
Jun 30, 2014 | 357.76M | 47.19M | 15.19% |
Jun 30, 2013 | 310.58M | -3.99M | -1.27% |
Jun 30, 2012 | 314.56M | 24.60M | 8.48% |
Jun 30, 2011 | 289.96M | 20.92M | 7.77% |
Jun 30, 2010 | 269.05M | 5.09M | 1.93% |
Jun 30, 2009 | 263.96M | 6.54M | 2.54% |
Jun 30, 2008 | 257.42M | 33.94M | 15.19% |
Jun 30, 2007 | 223.48M | 20.87M | 10.30% |
Jun 30, 2006 | 202.62M | 23.97M | 13.41% |
Jun 30, 2005 | 178.65M | 17.40M | 10.79% |
Jun 30, 2004 | 161.26M | 16.25M | 11.20% |
Jun 30, 2003 | 145.01M | 14.11M | 10.78% |
Jun 30, 2002 | 130.90M | 15.54M | 13.47% |
Jun 30, 2001 | 115.36M | 11.52M | 11.09% |
Jun 30, 2000 | 103.84M | 12.94M | 14.23% |
Jun 30, 1999 | 90.90M | 23.61M | 35.09% |
Jun 30, 1998 | 67.29M | 6.37M | 10.45% |
Jun 30, 1997 | 60.92M | 6.33M | 11.60% |
Jun 30, 1996 | 54.59M | 6.87M | 14.40% |
Jun 30, 1995 | 47.72M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.91B |
DaVita | 12.14B |
Solventum | 8.20B |
Charles River Laboratories International | 4.13B |
Incyte | 3.77B |
Bruker | 2.96B |
Exact Sciences | 2.50B |
United Therapeutics | 2.50B |
TECH News
- 2 days ago - Bio-Techne beats third-quarter estimates on improving demand for biotech products - Reuters
- 2 days ago - BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS - PRNewsWire
- 2 days ago - BIO-TECHNE DECLARES DIVIDEND - PRNewsWire
- 3 days ago - BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS - PRNewsWire
- 4 days ago - BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC - PRNewsWire
- 7 days ago - BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY - PRNewsWire
- 10 days ago - BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS - PRNewsWire
- 23 days ago - BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS - PRNewsWire